TGA
PI change on the agenda
TGA issues safety reminder and advises of updates to infliximab product information Changes to the product information of Remicade (infliximab) have been flagged by the TGA in a recent newsletter, …
Alleged advertising breaches
The TGA has begun proceedings against a clinic over alleged advertising breaches of compounded prescription-only therapeutic goods The Secretary of the Department of Health has begun Federal Court proceedings against …
Riding the wave of change
Pharmacists’ frontline role and clinical expertise makes them ideally placed to dispense medicinal cannabis and become a key partner in the patient journey For decades cannabis, or marijuana as it’s …
New drug: Erenumab for migraine
Learn more about this new option for people who have frequent attacks of migraine Injections of erenumab have recently been added to the list of drugs used for prophylaxis of …
Current system ‘creates vicious cycle of local stockpiling’
Latest system for medicines shortages reporting has had ‘major failings,’ says NPS MedicineWise’s new CEO, but recent legislation is set to improve the situation Medicine shortages are not a new …
Undeclared substances
The TGA has issued a safety advisory regarding BFB Be Fast Block Capsules, Big Penis U.S.A tablets and Lanky Genuine Capsules All three products pose a serious health risk and should …
Shortages continue
New advice on medicines shortages provided by regulators as shipping delays add another case to the list The TGA today advised that Prenoxad 1 mg/mL solution for injection in a …
Shortages roll on
The TGA has provided updated advice on the shortages of Anginine and Lycinate, as well as Clomid Arrow Pharmaceuticals, the sponsor of Anginine and Lycinate tablets, has advised the TGA …
Fixing the schedule
Changes to diclofenac, fluticasone and cannabis schedules confirmed by TGA The TGA’s Advisory Committee on Medicines Scheduling has confirmed earlier decisions to alter the scheduling of a number of widely …
Next steps: Consultation on strong opioid use and misuse
The TGA has commenced reviews into pack sizes, indications and label warnings for S8 opioids In response to rising numbers of opioid prescriptions and levels of overdose reaching “record levels”, …
New ‘hard-line approach’ to meds shortages
The Senate has passed legislation which will require pharmaceutical companies to report shortages of important medicines as they occur Based on the new legislation, medicine companies will have to report …
Sildenafil to remain script only
A committee has ruled against Viagra going OTC, saying the pharmacy setting is not equipped to provide medical diagnosis for underlying conditions of ED The Advisory Committee on Medicines Scheduling …